Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferry Ossendorp

Showing results (51-60 of 159) with videos related to

Pageof 16
Sort By:
Journal of Nanobiotechnology|June 6, 2022
M1-derived extracellular vesicles enhance photodynamic therapy and promote immunological memory in preclinical models of colon cancerRuben V Huis In 't Veld, Pablo Lara, Martine J Jager, et al.
Pharmaceutics|October 23, 2021
Zinc-Phthalocyanine-Loaded Extracellular Vesicles Increase Efficacy and Selectivity of Photodynamic Therapy in Co-Culture and Preclinical Models of Colon CancerPablo Lara, Ruben V Huis In 't Veld, Carla Jorquera-Cordero, et al.
Oncoimmunology|January 23, 2015
Two in one: improving synthetic long peptide vaccines by combining antigen and adjuvant in one moleculeGijs G Zom, Dmitri V Filippov, Gijsbert A van der Marel, et al.
Nuclear Medicine and Biology|July 13, 2004
New chelation strategy allows for quick and clean 99mTc-labeling of synthetic peptidesDik Blok, Hans I J Feitsma, Yvonne M C Kooy, et al.
JCI Insight|December 7, 2018
Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapyMarieke F Fransen, Mark Schoonderwoerd, Philipp Knopf, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 3, 2002
Effective immunotherapy of cancer in MUC1-transgenic mice using clonal cytotoxic T lymphocytes directed against an immunodominant MUC1 epitopeLukas C Heukamp, Thorbald van Hall, Ferry Ossendorp, et al.
Materials Today. Bio|April 21, 2026
Vaccination with cationic liposome-encapsulated CD4 and CD8 T cell neoepitopes induces superior tumor controlFelicia S Spitzer, Jeroen Heuts, Brett J Hos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 23, 2017
C1q-Dependent Dendritic Cell Cross-Presentation of In Vivo-Formed Antigen-Antibody ComplexesNataschja I Ho, Marcel G M Camps, Edwin F E de Haas, et al.
Cancer Immunology, Immunotherapy : CII|March 30, 2023
Immune checkpoint inhibition combined with targeted therapy using a novel virus-like drug conjugate induces complete responses in a murine model of local and distant tumorsRuben V Huis In 't Veld, Sen Ma, Rhonda C Kines, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 28, 2017
Hollow microneedle-mediated micro-injections of a liposomal HPV E7<sub>43-63</sub> synthetic long peptide vaccine for efficient induction of cytotoxic and T-helper responsesKoen van der Maaden, Jeroen Heuts, Marcel Camps, et al.
Pageof 16

Showing results (51-60 of 159) with videos related to

Sort By:
Pageof 16
Journal of Nanobiotechnology|June 6, 2022
M1-derived extracellular vesicles enhance photodynamic therapy and promote immunological memory in preclinical models of colon cancerRuben V Huis In 't Veld, Pablo Lara, Martine J Jager, et al.
Pharmaceutics|October 23, 2021
Zinc-Phthalocyanine-Loaded Extracellular Vesicles Increase Efficacy and Selectivity of Photodynamic Therapy in Co-Culture and Preclinical Models of Colon CancerPablo Lara, Ruben V Huis In 't Veld, Carla Jorquera-Cordero, et al.
Oncoimmunology|January 23, 2015
Two in one: improving synthetic long peptide vaccines by combining antigen and adjuvant in one moleculeGijs G Zom, Dmitri V Filippov, Gijsbert A van der Marel, et al.
Nuclear Medicine and Biology|July 13, 2004
New chelation strategy allows for quick and clean 99mTc-labeling of synthetic peptidesDik Blok, Hans I J Feitsma, Yvonne M C Kooy, et al.
JCI Insight|December 7, 2018
Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapyMarieke F Fransen, Mark Schoonderwoerd, Philipp Knopf, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 3, 2002
Effective immunotherapy of cancer in MUC1-transgenic mice using clonal cytotoxic T lymphocytes directed against an immunodominant MUC1 epitopeLukas C Heukamp, Thorbald van Hall, Ferry Ossendorp, et al.
Materials Today. Bio|April 21, 2026
Vaccination with cationic liposome-encapsulated CD4 and CD8 T cell neoepitopes induces superior tumor controlFelicia S Spitzer, Jeroen Heuts, Brett J Hos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 23, 2017
C1q-Dependent Dendritic Cell Cross-Presentation of In Vivo-Formed Antigen-Antibody ComplexesNataschja I Ho, Marcel G M Camps, Edwin F E de Haas, et al.
Cancer Immunology, Immunotherapy : CII|March 30, 2023
Immune checkpoint inhibition combined with targeted therapy using a novel virus-like drug conjugate induces complete responses in a murine model of local and distant tumorsRuben V Huis In 't Veld, Sen Ma, Rhonda C Kines, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 28, 2017
Hollow microneedle-mediated micro-injections of a liposomal HPV E7<sub>43-63</sub> synthetic long peptide vaccine for efficient induction of cytotoxic and T-helper responsesKoen van der Maaden, Jeroen Heuts, Marcel Camps, et al.
Pageof 16